Clinical Trial Update: Acarbose, Postprandial Hypotension and Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating acarbose for Type 2 diabetes with postprandial hypotension; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postprandial Hypotension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)

Snippet

Sponsor: University of British Columbia | Conditions: Type 2 Diabetes, Postprandial Hypotension | Phase 2 | Status: COMPLETED